HDM2 negatively affects the Chk2-mediated phosphorylation of p53

FEBS Letters

Volumn 579, Issue 12, 2005, Pages 2604-2608

  Bjørling Poulsen, Marina ^a   Meek, David ^b   Issinger, Olaf Georg ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Chk2; HDM2; p53; Phosphorylation; Protein kinase

Indexed keywords

CHECKPOINT KINASE 2; GLUTATHIONE TRANSFERASE; PROTEIN MDM2; PROTEIN P53; RECOMBINANT ENZYME;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME STABILITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; LEPIDOPTERA; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

EID: 18144424043     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.03.081     Document Type: Article

References (19)

1. D.W. Meek Mechanisms of switching on p53: a role for covalent modification Oncogene 18 1999 7666 7675
2. N.A. Barlev, L. Liu, N.H. Chehab, K. Mansfield, K.G. Harris, T.D. Halazonetis, and S.L. Berger Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
3. M. Gostissa, A. Hengstermann, V. Fogal, P. Sandy, S.E. Schwarz, M. Scheffner, and G. Del Sal Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 Embo J. 18 1999 6462 6471
4. R. Honda, H. Tanaka, and H. Yasuda Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett. 420 1997 25 27
5. S.R. Grossman, M.E. Deato, C. Brignone, H.M. Chan, A.L. Kung, H. Tagami, Y. Nakatani, and D.M. Livingston Polyubiquitination of p53 by a ubiquitin ligase activity of p300 Science 300 2003 342 344
6. S.Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev. 14 2000 289 300
7. A. Craig, M. Scott, L. Burch, G. Smith, K. Ball, and T. Hupp Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain EMBO Rep. 4 2003 787 792
8. O. Schon, A. Friedler, M. Bycroft, S.M. Freund, and A.R. Fersht Molecular mechanism of the interaction between MDM2 and p53 J. Mol. Biol. 323 2002 491 501
9. S. Banin, L. Moyal, S. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 281 1998 1674 1677
10. N. Dumaz, D.M. Milne, and D.W. Meek Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15 FEBS Lett. 463 1999 312 316
11. D.W. Meek The p53 response to DNA damage DNA Repair (Amst) 3 2004 1049 1056
12. A.L. Craig, and T.R. Hupp The regulation of CHK2 in human cancer Oncogene 23 2004 8411 8418
13. M. Bjorling-Poulsen, G. Seitz, B. Guerra, and O.G. Issinger The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas Int. J. Oncol. 23 2003 1015 1023
14. S. Bell, S. Hansen, and J. Buchner Refolding and structural characterization of the human p53 tumor suppressor protein Biophys. Chem. 96 2002 243 257
15. B. Guerra, S. Siemer, B. Boldyreff, and O.G. Issinger Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles FEBS Lett. 462 1999 353 357
16. T. Juven-Gershon, and M. Oren Mdm2: the ups and downs Mol. Med. 5 1999 71 83
17. J. Chen, V. Marechal, and A.J. Levine Mapping of the p53 and mdm-2 interaction domains Mol. Cell. Biol. 13 1993 4107 4114
18. M.A. McCoy, J.J. Gesell, M.M. Senior, and D.F. Wyss Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation Proc. Natl. Acad. Sci. USA 100 2003 1645 1648
19. H. Shimizu, and T.R. Hupp Intrasteric regulation of MDM2 Trends Biochem. Sci. 28 2003 346 349